These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23188490)

  • 1. Validation of the menstrual pictogram in women with leiomyomata associated with heavy menstrual bleeding.
    Larsen L; Coyne K; Chwalisz K
    Reprod Sci; 2013 Jun; 20(6):680-7. PubMed ID: 23188490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
    Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of total menstrual blood loss.
    Wyatt KM; Dimmock PW; Walker TJ; O'Brien PM
    Fertil Steril; 2001 Jul; 76(1):125-31. PubMed ID: 11438330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new menstrual pictogram for use with feminine products that contain superabsorbent polymers.
    Magnay JL; Nevatte TM; Seitz C; O'Brien S
    Fertil Steril; 2013 Dec; 100(6):1715-21.e1-4. PubMed ID: 24034941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of methods to measure menstrual blood loss.
    Magnay JL; O'Brien S; Gerlinger C; Seitz C
    BMC Womens Health; 2018 Aug; 18(1):142. PubMed ID: 30134884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy.
    Wilkens J; Chwalisz K; Han C; Walker J; Cameron IT; Ingamells S; Lawrence AC; Lumsden MA; Hapangama D; Williams AR; Critchley HO
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4664-71. PubMed ID: 18765509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers.
    Magnay JL; Nevatte TM; O'Brien S; Gerlinger C; Seitz C
    Fertil Steril; 2014 Feb; 101(2):515-22. PubMed ID: 24331833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study.
    Bradley LD; Singh SS; Simon J; Gemzell-Danielsson K; Petersdorf K; Groettrup-Wolfers E; Ren X; Zvolanek M; Seitz C
    Fertil Steril; 2019 Feb; 111(2):240-248. PubMed ID: 30527839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review.
    Magnay JL; O'Brien S; Gerlinger C; Seitz C
    BMC Womens Health; 2020 Feb; 20(1):24. PubMed ID: 32041594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.
    Chwalisz K; Larsen L; Mattia-Goldberg C; Edmonds A; Elger W; Winkel CA
    Fertil Steril; 2007 Jun; 87(6):1399-412. PubMed ID: 17307170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia.
    Ylikorkala O; Pekonen F
    Obstet Gynecol; 1986 Jul; 68(1):10-2. PubMed ID: 3523328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.
    Archer DF; Stewart EA; Jain RI; Feldman RA; Lukes AS; North JD; Soliman AM; Gao J; Ng JW; Chwalisz K
    Fertil Steril; 2017 Jul; 108(1):152-160.e4. PubMed ID: 28579415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.
    Fraser IS; McCarron G; Markham R; Resta T; Watts A
    Obstet Gynecol; 1986 Nov; 68(5):630-3. PubMed ID: 3763074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives on the menstrual pictogram for the assessment of heavy menstrual bleeding.
    Singh SS; Calaf Alsina J; Vannuccini S; Koga K; Lopes Silva-Filho A; Yang X; Estrade JP; Catherino W
    Hum Reprod Open; 2022; 2022(4):hoac048. PubMed ID: 36382010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
    Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
    J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oriahnn for fibroid-associated heavy menstrual bleeding.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):51-52. PubMed ID: 33830967
    [No Abstract]   [Full Text] [Related]  

  • 18. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.
    Janssen CA; Scholten PC; Heintz AP
    Obstet Gynecol; 1995 Jun; 85(6):977-82. PubMed ID: 7770270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Carr BR; Stewart EA; Archer DF; Al-Hendy A; Bradley L; Watts NB; Diamond MP; Gao J; Owens CD; Chwalisz K; Duan WR; Soliman AM; Dufek MB; Simon JA
    Obstet Gynecol; 2018 Nov; 132(5):1252-1264. PubMed ID: 30303923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of periodic blood loss: interindividual and intraindividual variations of pictorial blood loss assessment chart registrations.
    Hald K; Lieng M
    J Minim Invasive Gynecol; 2014; 21(4):662-8. PubMed ID: 24469275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.